| Financial Year |
March 31 2023 |
| Monetary Funds |
289,483,528.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
402,795,454.08 |
| Accounts Receivable |
493,515,136.44 |
| Advances to Suppliers |
65,504,142.10 |
| Other Receivables |
59,805,966.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
391,310,740.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
55,030,990.07 |
| Other Current Assets |
1,315,947.84 |
| Total Current Assets |
1,758,761,906.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
588,897,221.67 |
| Investment Properties |
-- |
| Fixed Assetes |
1,386,809,777.80 |
| Under-construction Projects |
116,413,747.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,641,283.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
175,317,000.98 |
| Other Non-Current Assets |
4,950,879.88 |
| Sub-Total of Non-Current Assets |
2,459,709,151.76 |
| Total Assets |
4,218,471,058.14 |
| Short-Term Loans |
1,251,152,404.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
321,000,000.00 |
| Accounts Payable |
426,223,301.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,714,718.26 |
| Taxes Payable |
58,090,594.37 |
| Interest Payable |
20,496,393.71 |
| Dividend Payable |
-- |
| Other payables |
96,054,992.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
244,780,116.66 |
| Other Current Liabilities |
406,253,304.57 |
| Sub-Total of Current Liabilities |
2,899,926,802.42 |
| Long-term Loans |
386,096,721.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
372,206,810.26 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
872,817,967.90 |
| Total Liabilities |
3,772,744,770.32 |
| Paid-In Capital(Or Share Stock) |
801,683,074.00 |
| Capital Surplus |
1,783,986,100.02 |
| Surplus Reserve |
94,210,199.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,242,363,284.64 |
| Minority Stockholder's Interest |
8,210,199.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
437,516,088.43 |
| Owner's Equity（Stockholder's Equity） |
445,726,287.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,218,471,058.14 |
